Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

BioMed Research International
Volume 2014 (2014), Article ID 247182, 6 pages
http://dx.doi.org/10.1155/2014/247182
Research Article

Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis

1Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
2Division of Gastroenterology, Department of Medicine, Tufts Medical Center, 800 Washington Street, P.O. Box 233, Boston, MA 02111, USA

Received 1 April 2014; Revised 3 June 2014; Accepted 4 June 2014; Published 9 July 2014

Academic Editor: Luis I. Terrazas

Copyright © 2014 Mitra Khumbatta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Elliott, A. M. Blum, J. Li, A. Metwali, and J. V. Weinstock, “Preprosomatostatin messenger RNA is expressed by inflammatory cells and induced by inflammatory mediators and cytokines,” The Journal of Immunology, vol. 160, no. 8, pp. 3997–4003, 1998. View at Google Scholar · View at Scopus
  2. T. Talme, J. Ivanoff, M. Hägglund, R. J. J. Van Neerven, A. Ivanoff, and K. G. Sundqvist, “Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3,” Clinical and Experimental Immunology, vol. 125, no. 1, pp. 71–79, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Blum, A. Metwali, R. C. Mathew, G. Cook, D. Elliott, and J. V. Weinstock, “Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-γ secretion,” The Journal of Immunology, vol. 149, no. 11, pp. 3621–3626, 1992. View at Google Scholar · View at Scopus
  4. J. V. Weinstock, A. M. Blum, and T. Malloy, “Macrophages within the granulomas of murine Schistosoma mansoni are a source of a somatostatin 1-14-like molecule,” Cellular Immunology, vol. 131, no. 2, pp. 381–390, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. D. E. Elliott, A. Metwali, A. M. Blum, M. Sandor, R. Lynch, and J. V. Weinstock, “T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA,” Journal of Immunology, vol. 153, no. 3, pp. 1180–1186, 1994. View at Google Scholar · View at Scopus
  6. D. E. Elliott and J. V. Weinstock, “Granulomas in murine schistosomiasis mansoni have a somatostatin immunoregulatory circuit,” Metabolism: Clinical and Experimental, vol. 45, no. 1, pp. 88–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. G. E. Krassas, N. Pontikides, D. Doukidis, G. Heufelder, and A. E. Heufelder, “Serum levels of tumor necrosis factor-α, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues,” Thyroid, vol. 11, no. 12, pp. 1115–1122, 2001. View at Google Scholar · View at Scopus
  8. T. Zhu, G. Dong, G. Huang, X. Fan, B. Liu, and Z. Zhang, “The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats,” Zhonghua Yi Xue Za Zhi, vol. 87, no. 5, pp. 345–347, 2007. View at Google Scholar · View at Scopus
  9. G. Peluso, O. Petillo, M. A. B. Melone, G. Mazzarella, M. Ranieri, and G. F. Tajana, “Modulation of cytokine production in activated human monocytes by somatostatin,” Neuropeptides, vol. 30, no. 5, pp. 443–451, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zhang, W. Huang, F. Li, S. Feng, K. Kang, and J. Xu, “Octreotide for the treatment of systemic lupus erythematosus: clinical effects and an in vitro study on its therapeutic mechanism,” Lupus, vol. 20, no. 11, pp. 1172–1181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Muscettola and G. Grasso, “Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells,” Immunobiology, vol. 180, no. 4-5, pp. 419–430, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. O. F. Villa and R. E. Kuhn, “Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena,” Parasitology, vol. 112, no. 6, pp. 561–570, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Larralde, R. M. Montoya, J. Sotelo et al., “Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginata bovine cysticercosis, and human E. granulosus hydatidosis,” Bulletin of the French Society for Parasitology, vol. 8, article S8B, 1990. View at Google Scholar
  14. O. Villa and R. Kuhn, Antigenic and Immunogenic Analysis of Taenia crassiceps and Taenia solium Using Sera from Their Natural Intermediate Hosts, vol. 39, All Star Bucking Bulls, 1991.
  15. J. Kunz, B. Kalinna, V. Watschke, and E. Geyer, “Taenia crassiceps metacestode vesicular fluid antigens shared with the Taenia solium larval stage and reactive with serum antibodies from patients with neurocysticercosis,” Zentralblatt fur Bakteriologie, vol. 271, no. 4, pp. 510–520, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Sciutto, G. Fragoso, M. Baca, V. de la Cruz, L. Lemus, and E. Lamoyi, “Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection,” Infection and Immunity, vol. 63, no. 6, pp. 2277–2281, 1995. View at Google Scholar · View at Scopus
  17. A. Garza, D. J. Tweardy, J. Weinstock, B. Viswanathan, and P. Robinson, “Substance P signaling contributes to granuloma formation in taenia crassiceps infection, a murine model of cysticercosis,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 597086, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Robinson, A. C. White, D. E. Lewis, J. Thornby, E. David, and J. Weinstock, “Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis,” Infection and Immunity, vol. 70, no. 8, pp. 4534–4538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Robinson, R. L. Atmar, D. E. Lewis, and A. C. White Jr., “Granuloma cytokines in murine cysticercosis,” Infection and Immunity, vol. 65, no. 7, pp. 2925–2931, 1997. View at Google Scholar · View at Scopus
  20. E. J. Pearce and A. S. MacDonald, “The immunobiology of schistosomiasis,” Nature Reviews Immunology, vol. 2, no. 7, pp. 499–511, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. L. I. Terrazas, M. Cruz, M. Rodríguez-Sosa, R. Bojalil, F. García-Tamayo, and C. Larralde, “Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps,” Parasitology Research, vol. 85, no. 2, pp. 135–141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Low, V. Otero-Corchon, A. F. Parlow et al., “Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth,” The Journal of Clinical Investigation, vol. 107, no. 12, pp. 1571–1580, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. K. Halonen, F.-C. Chiu, and L. M. Weiss, “Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes,” Infection and Immunity, vol. 66, no. 10, pp. 4989–4993, 1998. View at Google Scholar · View at Scopus
  24. W. Däubener, N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer, and U. Hadding, “A new, simple, bioassay for human IFN-γ,” Journal of Immunological Methods, vol. 168, no. 1, pp. 39–47, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Pelloux, G. Pernod, B. Polack et al., “Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells,” Parasitology Research, vol. 82, no. 7, pp. 598–603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Hernanz, E. Tato, M. De la Fuente, E. de Miguel, and F. Arnalich, “Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1β, interleukin-6 and tumor necrosis factor-α production by whole blood cells from healthy young and old subjects,” Journal of Neuroimmunology, vol. 71, no. 1-2, pp. 25–30, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Komorowski and H. Stepień, “Somatostatin (SRIF) stimulates the release of interleukin-6 (IL-6) from human peripheral blood monocytes (PBM) in vitro,” Neuropeptides, vol. 29, no. 2, pp. 77–81, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Paran, D. Kidron, A. Mayo et al., “Somatostatin analogue treatment attenuates histological findings of inflammation and increases mRNA expression of interleukin-1 beta in the articular tissues of rats with ongoing adjuvant-induced arthritis,” Rheumatology International, vol. 25, no. 5, pp. 350–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Lang, E. Sakhnini, H. H. Fidder, Y. Maor, S. Bar-Meir, and Y. Chowers, “Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells,” Liver International, vol. 25, no. 4, pp. 808–816, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. B. L. Spangelo, S. Horrell, A. L. Goodwin, S. Shroff, and W. D. Jarvis, “Somatostatin and gamma-aminobutyric acid inhibit interleukin-1β- stimulated release of interleukin-6 from rat C6 glioma cells,” NeuroImmunoModulation, vol. 11, no. 5, pp. 332–340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Chowers, L. Cahalon, M. Lahav et al., “Somatostatin through its specific receptor inhibits spontaneous and TNF-α- and bacteria-induced IL-8 and IL-1β secretion from intestinal epithelial cells,” Journal of Immunology, vol. 165, no. 6, pp. 2955–2961, 2000. View at Publisher · View at Google Scholar · View at Scopus